Effect of eprosartan on the sympathetic response to cold pressor test in healthy volunteers

Autonomic Neuroscience : Basic & Clinical
Anita IsraelMaria del Rosario Garrido

Abstract

The aim of this study was to evaluate the effect of short-term administration of the AT1 angiotensin II receptor antagonist, eprosartan, on the sympathetic response to cold pressor test (CPT) in normotensive healthy volunteers. Sixty-nine healthy volunteers were included in this double-blind placebo-controlled study. Blood pressure and heart rate were determined before and 175 min after oral administration of placebo, losartan (50 mg) or eprosartan (600 mg). Immediately, the subjects underwent CPT and then the same hemodynamic variables were measured. CPT increased arterial blood pressure (systolic, diastolic and mean) and HR in placebo-treated group. Pretreatment with a single dose of losartan or eprosartan blunted CPT-induced pressor response, but not the rise in heart rate. Our results demonstrate that endogenous angiotensin II, through stimulation of AT1 receptor, supports sympathetic mediated stress-response in humans.

References

Oct 1, 1992·Postgraduate Medicine·R S Eliot
Jan 1, 1992·The Japanese Journal of Physiology·K YamamotoT Mano
May 1, 1992·Clinical and Experimental Pharmacology & Physiology·S MinatoguchiH Majewski
May 1, 1992·Endocrine Reviews·J M Saavedra
May 31, 1990·Biochemical and Biophysical Research Communications·F FyhrquistT Tikkanen
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E Castrén, J M Saavedra
Jan 1, 1986·European Journal of Clinical Pharmacology·B P McGrath, L F Arnolda
Mar 11, 1988·The American Journal of Medicine·A ZoppiR Fogari
Jan 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·J C Liao, B G Zimmerman
Mar 1, 1972·Circulation Research·C M FerrarioJ W McCubbin
Jan 1, 1984·Journal of Cardiovascular Pharmacology·K J CattG Aguilera
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Jan 4, 1994·European Journal of Pharmacology·M Cierco, A Israel
Mar 1, 1997·The American Journal of Physiology·R H WorckH Dige-Petersen
Apr 16, 1998·Hypertension·C M dos SantosL C Michelini
Dec 2, 1998·Basic Research in Cardiology·A DendorferP Dominiak
Jul 9, 2004·Annals of the New York Academy of Sciences·J M SaavedraJ Zhou

❮ Previous
Next ❯

Citations

Mar 18, 2008·British Journal of Clinical Pharmacology·Henrik VaseErling B Pedersen
Jan 5, 2011·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·André SchulzHartmut Schächinger
May 27, 2010·Journal of Hypertension·Alain G Dupont, Sofie Brouwers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.